Profile: Remicalm, LLC specializes in medical diagnostic and imaging devices. We offer cancer diagnostic, screening, imaging and monitoring technologies. Our Identafi™ technology is used to detect pre-cancerous cells of oral cancer, cervical cancer, gastrointestinal cancer and skin cancer. In oral cancer, it identifies biochemical and morphological changes in cells of the mouth, throat, tongue and tonsils. Our technology can spot the exact location of pre-cancerous cells and determine the extent of the disease in the area being screened. The metabolic information obtained with the use of these devices enable the medical professional to achieve increased efficacy in early & accurate screening, diagnosis and monitoring of many cancers. The Identafi™ core technologies enable the development and introduction of a suite of cancer screening and diagnostic products. These screening and diagnostic products are housed in a handheld, cordless unit designed for use in the offices of physicians, dentists, specialists & general practitioners, for the screening and diagnosis of cancers and pre-cancerous lesions.